Subscribe To
Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update
NEW YORK, March 06, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company for which Cellectis owns 49.1% (as of December 31, 2022) of […] The post Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update appeared first...
Read More
Posted: Mar 6 2023, 21:30
Author Name: forextv
Views: 082166